Standardizing patient-reported outcomes across diseases: development of a novel generic patient-reported outcome set
Frontiers in Health Services · 02.10.2025 · 5
DOI: 10.3389/frhs.2025.1497055 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Health Services, online erschienen am 02.10.2025. Verfasst von Preston Long und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Outcomes Research, Medical University of Vienna, Vienna, Austria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative.
Abstract (Originalsprache)
Objectives
Patient-reported outcomes (PROs) are an essential component in the implementation of value-based health care. Up to now, no consensus exists on the appropriateness of PROs used across diseases, e.g., to allow for comparability or to assess disease impact. The aim of this study was to develop an international, multi-stakeholder consensus on a generic PRO set applicable for different stakeholders and diseases within of the Health Outcomes Observatory (H2O) project funded by the EU Innovative Medicines Initiative.
Methods
To begin, a literature review was conducted to identify the most frequently utilized generic PROs followed by a three-round Delphi consensus procedure. The resulting outcome set was then cross-referenced with disease-specific outcome sets for lung and metastatic breast cancer, diabetes, and inflammatory bowel diseases to identify overlaps and gaps. Lastly, the identified generic outcome domains were mapped to the Max Neef's human needs model to explore the degree to which the generic domains address a general concept of wellbeing.
Results
The literature search resulted in 2357 articles from which 190 PROMs and their measured domains were extracted. The Delphi consensus procedure reduced these to 10 core domains (mental, physical and social wellbeing, overall health status, fatigue, pain, sleep quality, sexuality, self-efficacy, treatment satisfaction). In comparison to the human needs model, needs such as identity and leisure were disregarded.
Conclusions
The H2O generic outcome set presents a disease-generic, domain-centered PRO framework building the groundwork for health data spaces and supporting consistency in treatment outcomes across different sites, settings, and patient populations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Outcomes Research, Medical University of Vienna, Vienna, Austria.
- Medizinische Klinik m. S. Psychosomatik, Charité University Medicine Berlin, Berlin, Germany.
- Department of Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria.
- Österreichische Morbus Crohn/Colitis ulcerosa Vereinigung (ÖMCCV), Vienna, Austria.
- Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
- Research & Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.
Förderung
- Innovative Medicines Initiative
Zitieren
APA
Long, P., Rogge, A., Porth, A. K., Gross, E., Fierens, L., de Rooij, B. H., Kamminga, N., & Stamm, T. (2025). Standardizing patient-reported outcomes across diseases: development of a novel generic patient-reported outcome set. Frontiers in Health Services, 5. https://doi.org/10.3389/frhs.2025.1497055
Vancouver
Long P, Rogge A, Porth AK, Gross E, Fierens L, de Rooij BH, et al. Standardizing patient-reported outcomes across diseases: development of a novel generic patient-reported outcome set. Frontiers in Health Services. 2025;5. doi:10.3389/frhs.2025.1497055
BibTeX
@article{Long2025,
author = {Long, Preston and Rogge, Alize and Porth, Ann-Kristin and Gross, Evelyn and Fierens, Liselotte and de Rooij, Belle H and Kamminga, Nadia and Stamm, Tanja},
title = {Standardizing patient-reported outcomes across diseases: development of a novel generic patient-reported outcome set},
journal = {Frontiers in Health Services},
year = {2025},
volume = {5},
doi = {10.3389/frhs.2025.1497055}
}
EUVIMED